Cargando…

Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

Liraglutide is a glucagon-like peptide 1 (GLP-1) analog indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise in adults. Liraglutide lowers blood glucose levels by stimulating insulin secretion and decreasing glucagon release in glucose-dependent manners, increas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Micale, Sara J., Kane, Michael P., Hogan, Eileen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814067/ https://www.ncbi.nlm.nih.gov/pubmed/24222881 http://dx.doi.org/10.1155/2013/703925

Ejemplares similares

Effectiveness of Liraglutide in Type II Diabetes Mellitus Management: Experience in Emirati Patients
por: Ghuman, Nasrullah K, et al.
Publicado: (2015)

Liraglutide with Lifestyle Intervention in Adolescents with Overweight/Obesity, Nonalcoholic Fatty Liver Disease, and Type II Diabetes Mellitus
por: Kohut, Taisa, et al.
Publicado: (2021)

Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus
por: Bruinstroop, Eveline, et al.
Publicado: (2018)

Liraglutide in the management of type 2 diabetes
por: Wajcberg, Estela, et al.
Publicado: (2010)

Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
por: Jacobsen, Lisbeth V., et al.
Publicado: (2015)

The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report
por: Hirai, Hiroyuki, et al.
Publicado: (2016)

Antivirals/glucocorticoids: Diabetes mellitus and ALT elevation following off-label use in COVID-19: case report
Publicado: (2020)

Liraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectives
por: Edavalath, Mahamood, et al.
Publicado: (2010)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
por: Mader, Julia K., et al.
Publicado: (2016)

Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus
por: Wilbrink, Francis J, et al.
Publicado: (2018)

Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients
por: Frontino, Giulio, et al.
Publicado: (2021)

Spontaneous Resolution of Primary Hyperparathyroidism in Parathyroid Adenoma
por: Micale, Sara J., et al.
Publicado: (2012)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Neumiller, Joshua J, et al.
Publicado: (2010)

Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus
por: Shang, Junjie, et al.
Publicado: (2021)

Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report
por: Matsumoto, Yuko, et al.
Publicado: (2017)

Pediatric osmotic demyelination syndrome in a case of type 1 diabetes mellitus with diabetic ketoacidosis
por: Chaudhary, Ashlesha, et al.
Publicado: (2022)

Short-term monotherapy with Liraglutide for weight management: A case study
por: Almarshad, Feras
Publicado: (2019)

Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
por: Vega-Hernandez, Gabriela, et al.
Publicado: (2017)

Efficacy and safety of liraglutide in patients with type 2 diabetes mellitus and severe obstructive sleep apnea
por: Jiang, Wenlong, et al.
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Success story of GLP-1 agonist (Liraglutide) treatment in someone with type 1 diabetes: a life transformed
por: Heald, Adrian H., et al.
Publicado: (2023)

Sevoflurane: Nephrogenic diabetes insipidus following off-label use: case report
Publicado: (2022)

Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study
por: del Olmo-García, Maria Isabel, et al.
Publicado: (2020)

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
por: Minze, Molly G, et al.
Publicado: (2016)

Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?
por: Kawata, Takehiro, et al.
Publicado: (2014)

Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
por: Tian, Feng, et al.
Publicado: (2018)

Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
por: Bizino, Maurice B., et al.
Publicado: (2019)

Liraglutide: A review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus
por: Dharmalingam, Mala, et al.
Publicado: (2011)

Guideline for the management of pediatric off-label use of drugs in China (2021)
por: Meng, Min, et al.
Publicado: (2022)

Hypoglycemia associated with off-label sitagliptin use
por: Whitley, Heather P, et al.
Publicado: (2008)

Successful use of liraglutide in a female patient with type 1 Gaucher disease, type 2 diabetes mellitus and obesity
por: Topaloğlu, Ömercan, et al.
Publicado: (2023)

Unfavorable Effects of Low-carbonhydrate Diet in a Pediatric Patient with Type 1 Diabetes Mellitus
por: Güleryüz, Ceren, et al.
Publicado: (2023)

The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis
por: Zhang, Jiudan, et al.
Publicado: (2021)

Delayed type hypersensitivity injection site reaction and tolerance induction to liraglutide for the treatment of obesity
por: Yaneva, Martina, et al.
Publicado: (2023)

Off-label use of intravitreal triamcinolone acetonide for diabetic macular edema in a pregnant patient
por: Fazelat, Ahad, et al.
Publicado: (2011)

Potential of liraglutide in the treatment of patients with type 2 diabetes
por: Deacon, Carolyn F
Publicado: (2009)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
por: Rigato, Mauro, et al.
Publicado: (2014)

Hypocalcemia secondary to hypomagnesemia in a patient on liraglutide
por: Habnouny, J.E.L., et al.
Publicado: (2020)

Hydroxychloroquine: Hepatocellular type II ﬁbrinogen inclusions following off-label treatment: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cegatg6s72bj5d333v8btsn9mp